GlassScriptPhysician profile
Brittany Hearn
NPI 1427551779
$1,161.30
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $505 · 2022: $553 · 2023: $103.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $103.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $103.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $462.49 | 2021-2023 | |
| Celgene Corporation | $108.46 | 2021-2022 | |
| Janssen Biotech, INC. | $63.14 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $61.05 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $50.98 | 2022-2023 | Ofev |
| Melinta Therapeutics, LLC | $50.31 | 2022-2023 | Vabomere, Orbactiv, Kimyrsa |
| Pfizer INC. | $41.41 | 2021-2022 | |
| Advanced Respiratory, INC | $35.34 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $35.31 | 2021 | |
| Phadia US INC. | $32.05 | 2021-2022 | |
| Qol Medical, LLC | $29.39 | 2021 | |
| Harmony Biosciences LLC | $24.03 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $18.88 | 2022 | |
| Jazz Pharmaceuticals INC. | $17.23 | 2023 | |
| Dynavax Technologies Corporation | $15.78 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $14.17 | 2022 | |
| Ucb, INC. | $13.74 | 2022 | |
| Mylan Specialty L.P. | $13.50 | 2021 | |
| Janssen Pharmaceuticals, INC | $13.09 | 2021 | |
| Ardelyx, INC. | $12.91 | 2023 | Ibsrela |
| Grifols USA, LLC | $12.24 | 2021 | |
| Amgen INC. | $12.17 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $11.99 | 2022 | |
| La Jolla Pharmaceutical Company | $11.64 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brittany Hearn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.